Barriers to Utilization of Family Medicine Services in Jordan: A Cross-Sectional Study of Patient Perceptions and Systemic Challenges

Abstract

This article explores the revolutionary role of DNA analysis technologies in transforming the early diagnosis of blood diseases. By examining genetic profiling, next-generation sequencing (NGS), liquid biopsy, and artificial intelligence–driven bioinformatics, this review highlights the transformative potential of personalized genomic medicine. Early and precise detection enables preemptive interventions, improved patient monitoring, and targeted therapeutic strategies, thereby enhancing survival outcomes in both hematologic malignancies and inherited blood disorders.